StockData
LMMYOTCServices-Educational ServicesFiscal year ends May 31

Exousia Bio, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Jun 16, 2026
$0.01−0.00 (-18.29%)

Close on Oct 19, 2026

Market cap
$175.47K
P/E (TTM)
–
Dividend yield
–

SEC filings

18 of Exousia Bio's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QFeb 28, 2026Jun 16, 2026SEC EDGAR
Quarterly report10-QNov 30, 2025Mar 17, 2026SEC EDGAR
Current report8-KNov 11, 2025Nov 17, 2025SEC EDGAR
Quarterly report10-QAug 31, 2025Nov 17, 2025SEC EDGAR
Annual report10-KMay 31, 2025Oct 17, 2025SEC EDGAR
Quarterly report10-QFeb 28, 2025Apr 24, 2025SEC EDGAR
Quarterly report10-QNov 30, 2024Jan 10, 2025SEC EDGAR
Current report8-KDec 6, 2024Dec 17, 2024SEC EDGAR
Quarterly report10-QAug 31, 2024Oct 11, 2024SEC EDGAR
Annual report10-KMay 31, 2024Aug 30, 2024SEC EDGAR
Current report8-KJul 23, 2024Aug 29, 2024SEC EDGAR
Quarterly report10-QFeb 29, 2024Apr 15, 2024SEC EDGAR
Quarterly report10-QNov 30, 2023Jan 16, 2024SEC EDGAR
Annual report, amended10-K/AMay 31, 2023Nov 16, 2023SEC EDGAR
Quarterly report10-QAug 31, 2023Oct 11, 2023SEC EDGAR
Annual report10-KMay 31, 2023Sep 1, 2023SEC EDGAR
Quarterly report10-QFeb 28, 2023May 8, 2023SEC EDGAR
Current report8-KMar 15, 2023Mar 17, 2023SEC EDGAR